AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2024
Dec 23, 2024
35200_dirs_2024-12-23_c0e98b80-481e-4d01-9522-9dced62e2912.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-12-19
Reporting Person: Graff Jeremy R. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-19 | Stock Option (right to buy) | $0.24 | A | 47697 | Acquired | 2034-12-19 | Common Stock (47697) | Direct |
Footnotes
F1: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.